Reuters logo
BRIEF-Spago Nanomedical signs deal with Charles River Laboratories for preclinical studies
2017年6月8日 / 早上7点19分 / 5 个月前

BRIEF-Spago Nanomedical signs deal with Charles River Laboratories for preclinical studies

June 8 (Reuters) - SPAGO NANOMEDICAL AB (PUBL)

* ANNOUNCE AGREEMENT WOTH CHARLES RIVER LABORATORIES FOR PRECLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below